GAS5 and non-small cell lung carcinoma: A diminished expression of GAS5 compared to that in normal tissue has been reported in multiple cancers, and this downregulation has been related to diminished apoptosis, increased proliferation, and poor prognosis in breast, pancreatic, cervical, bladder, and gastric cancers, as well as NSCLC [156].